Research desks at Stockpro Online and 3 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
Stockpro Online and 3 other registered desks issued 13 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 13 buys against 0 sells — covering 5 stocks.
YASHO attracted 4 separate recommendations from registered analysts — Stockpro Online issued a buy at ₹4,200 targeting ₹4,400 (stop ₹4,000); Stockpro Online issued a buy at ₹4,200 targeting ₹4,600 (stop ₹4,000); Stockpro Online issued a buy at ₹4,200 targeting ₹4,500 (stop ₹4,000); Stockpro Online issued a buy at ₹4,200 targeting ₹4,300 (stop ₹4,000).
RAIN attracted 3 separate recommendations from registered analysts — Zee Business issued a buy at ₹227 targeting ₹240 (stop ₹225); Zee Business issued a buy at ₹232 targeting ₹240 (stop ₹225); Zee Business issued a buy at ₹232 targeting ₹248 (stop ₹225).
WOCKPHARMA was flagged for a buy by Zee Business at ₹1,962, targeting ₹2,160 — a potential upside of +10.1%, with a stoploss at ₹1,860. The risk-to-reward ratio stands at 1:1.9.
Also covered: GAIL (₹175 → ₹190) via Zee Business, Ndtv Profit; PAYTM (₹59 → ₹70) via Cnbc Awaaz.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.